GeoVax Labs, Inc. (GOVX) P/E Ratio History
Deep ValueTrading at -0.0x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2006–2006
Loading P/E history...
P/E Ratio Analysis
As of September 24, 2026, GeoVax Labs, Inc. (GOVX) trades at a price-to-earnings ratio of -0.0x, with a stock price of $0.39 and trailing twelve-month earnings per share of $-4.47.
The current P/E is 100% below its 5-year average of 673400.0x. Over the past five years, GOVX's P/E has ranged from a low of 673400.0x to a high of 673400.0x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.7x, GOVX trades at a 100% discount to its sector peers. The sector includes 225 companies with P/E ratios ranging from 0.0x to 167.0x.
Relative to the broader market, GOVX trades at a notable discount to the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our GOVX DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
GOVX Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
GOVX P/E vs Peers
Vaccines and Infectious Disease peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 4.2Lowest | -Best | +307% | |
| $2B | 77.5 | -Best | +503%Best | |
| $227M | 9.6 | -Best | -60% | |
| $114M | 6.7 | -Best | +150% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
GOVX Historical P/E Data (2006–2006)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2006 Q4 | Dec 31 2006 | $999999.00 | $1.49 | 673400.0x | +0% |
Average P/E for displayed period: 673400.0x
GOVX Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
20+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
GOVX — Frequently Asked Questions
Quick answers to the most common questions about buying GOVX stock.
What is GOVX's P/E ratio?
GeoVax Labs, Inc. (GOVX) trailing twelve-month P/E ratio is -0.0x, based on TTM diluted EPS of $-4.47. The 5-year average P/E is 673400.0x and the historical range spans 673400.0x to 673400.0x.
Is GOVX stock overvalued or undervalued?
GOVX current P/E: -0.0x. 5-year average P/E: 673400.0x. Percentile: 0th.
Is GOVX stock expensive?
GOVX is fairly valued relative to its own history. The current P/E of -0.0x is near the 5-year average of 673400.0x (0th percentile of historical range).
What is GOVX's historical P/E range?
Over the past 5 years, GOVX's P/E ratio has ranged from 673400.0x to 673400.0x, with a median of 673400.0x and an average of 673400.0x. The current P/E of -0.0x places the stock at the 0th percentile of this range. Full historical data spans 2006–2006.
How does GOVX's P/E compare to the S&P 500?
GOVX current P/E: -0.0x. S&P 500 median P/E: 25.3x.
How does GOVX's valuation compare to Healthcare peers?
GeoVax Labs, Inc. P/E of -0.0x can be benchmarked against Healthcare peers in the comparison table on this page.
What is GOVX's PEG ratio?
GOVX PEG ratio is N/A, based on a P/E of -0.0x and EPS growth of 81.4%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is GOVX's earnings yield?
GOVX earnings yield is N/A, the inverse of its -0.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.